tetano
Editor, Senior Moderator
Expert Rev Anti Infect Ther
. 2020 Sep 12.
doi: 10.1080/14787210.2021.1823832. Online ahead of print.
The effect of antivirals on COVID-19: a systematic review
Nafisa Hussain[SUP] 1 [/SUP], Anusha Yoganathan[SUP] 1 [/SUP], Savini Hewage[SUP] 2 [/SUP], Samiha Alom[SUP] 3 [/SUP], Amer Harky[SUP] 4 [/SUP]
Affiliations
Abstract
Introduction: Coronavirus Disease 2019 is a contagious infection which has infected millions worldwide. The objective of this systematic review is to identify studies pertaining to antivirals, both as sole and combined therapies, in COVID-19 patients and review the clinical outcomes of these treatment methods.
Areas covered: A systematic review was conducted using Preferred Reporting Items or Systematic Reviews and Meta-analysis (PRISMA) guidelines. A literature search was done on Medline, Global Health, and EMBASE using keywords and MeSH terms relevant to COVID- 19 and antivirals. Limits were put on date to obtain articles between December 2019 to May 2020 (the time at which the search was performed). 776 articles were identified and screened. After screening, 16 studies were included. The narrative synthesis revealed three key themes (1) Use of antivirals only (such as lopinavir, umifenovir, and remdesivir), (2) Use of lopinavir-ritonavir alongside other treatments and (3) Use of other antivirals in combination with other treatments.
Expert opinion: Using antivirals in combination with other treatments has potential, however further randomised controlled trials with larger sample sizes are required to identify the best candidate components that should comprise combined treatments for COVID-19. This should optimise treatment efficacy and improve patient outcomes.
Keywords: Antiviral; COVID-19; Coronavirus; Treatment.
. 2020 Sep 12.
doi: 10.1080/14787210.2021.1823832. Online ahead of print.
The effect of antivirals on COVID-19: a systematic review
Nafisa Hussain[SUP] 1 [/SUP], Anusha Yoganathan[SUP] 1 [/SUP], Savini Hewage[SUP] 2 [/SUP], Samiha Alom[SUP] 3 [/SUP], Amer Harky[SUP] 4 [/SUP]
Affiliations
- PMID: 32924650
- DOI: 10.1080/14787210.2021.1823832
Abstract
Introduction: Coronavirus Disease 2019 is a contagious infection which has infected millions worldwide. The objective of this systematic review is to identify studies pertaining to antivirals, both as sole and combined therapies, in COVID-19 patients and review the clinical outcomes of these treatment methods.
Areas covered: A systematic review was conducted using Preferred Reporting Items or Systematic Reviews and Meta-analysis (PRISMA) guidelines. A literature search was done on Medline, Global Health, and EMBASE using keywords and MeSH terms relevant to COVID- 19 and antivirals. Limits were put on date to obtain articles between December 2019 to May 2020 (the time at which the search was performed). 776 articles were identified and screened. After screening, 16 studies were included. The narrative synthesis revealed three key themes (1) Use of antivirals only (such as lopinavir, umifenovir, and remdesivir), (2) Use of lopinavir-ritonavir alongside other treatments and (3) Use of other antivirals in combination with other treatments.
Expert opinion: Using antivirals in combination with other treatments has potential, however further randomised controlled trials with larger sample sizes are required to identify the best candidate components that should comprise combined treatments for COVID-19. This should optimise treatment efficacy and improve patient outcomes.
Keywords: Antiviral; COVID-19; Coronavirus; Treatment.